Prosocial Behavior Clinical Trial
Official title:
The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality
The goal of this study is to assess the effects of LSD on neural synchrony, prosocial behavior, and relationship quality in healthy romantic couples.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | January 1, 2024 |
Est. primary completion date | January 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Written Informed Consent - Understanding the procedures and the risks associated with the study. - Age between 18 and 35 years old. - Being in a steady relationship for at least 6 months. - Proficient knowledge of the English language - Previous experience with at least one psychedelic drug (psilocybin, LSD, mescaline, Ayahuasca, DMT, 5-MeO-DMT), but not within the past 3 months - Absence of any major medical condition as determined by medical examination and laboratory analysis - Absence of any major psychological condition as determined by medical examination - Free from psychotropic medication - Participants must be willing to refrain from taking illicit psychoactive substances during the study. - Participants must be willing to drink only alcohol-free liquids and no coffee, black or green tea, or energy drink after midnight of the evening before the study session, as well as during the study day. - Participants must be willing not to drive a traffic vehicle or to operate machines within 24 h after substance administration. - Normal weight, body mass index (weight/height2) between 18 and 28 kg/m2 Exclusion Criteria: - History of drug addiction (determined by the medical questionnaire, drug questionnaire and medical examination) - Previous experience of serious side effects to psychedelic drugs (anxiety or panic attacks) - Pregnancy or lactation - Hypertension (diastolic > 90 mmHg; systolic > 140 mmHg) - Current or history of psychiatric disorder (determined by the medical questionnaire and medical examination) - Psychotic disorder in first-degree relatives - Any chronic or acute medical condition - History of cardiac dysfunctions (arrhythmia, ischemic heart disease,…) - For women: no use of a reliable contraceptive - Tobacco smoking (>20 per day) - Excessive drinking (>20 alcoholic consumptions per week) - Experience with a full dose of a psychedelic within the last three months - Current use of SSRI medication |
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht University | Maastricht |
Lead Sponsor | Collaborator |
---|---|
Maastricht University |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Relationship quality | Relationship quality will be measured via subjective reports on a number of scales: the couples satisfaction index (CSI), the perceived partners responsiveness scale (PPRS), the experiences in close relationship scale (ECR), and the interpersonal reactivity index for couples (IRI-C). | At baseline, 2 days follow-up (CSI) and at 4 days follow-up (CSI, PPRS, ECR, IRI-C). | |
Other | Sexual function | Sexual function will be measured via subjective reports on a number of scales: the global measure of sexual satisfaction (GMSEX), the female sexual function index (FSFI), and the international index of erectile function (IIEF). | At baseline, 2 days follow-up (GMSEX), and at 4 days follow-up (GMSEX, FSFI/IIEF). | |
Other | Well-being | Well-being will be measured via subjective reports on the satisfaction with life scale (SWLS). | On the acute dosing day, at baseline (-0.5 hours) and at 7 hours after substance administration, at the 2 day follow-up, and at the 4 day follow-up. | |
Other | Subjective drug effects | Subjective drug effects will be measured via subjective reports on the altered states of consciousness rating scale (5D-ASC), and on the ego dissolution inventory (EDI). | On the acute dosing day, 7 hours after substance administration. | |
Other | Real-time social behavior | Real-time social behavior will be assessed via subjective reports on experience sampling questions (ESQ) in the Ethica app. | Daily up until 3 days after the acute dosing day. | |
Other | LSD concentrations | Blood samples will be collected to measure LSD concentrations | Acute dosing day:baseline (-0.5 hour), at 1.5, 2.5, 3.5, 5, and at 7 hours. | |
Other | Oxytocin concentrations | Blood samples will be collected to measure oxytocin | Acute dosing day:baseline (-0.5 hour), at 1.5, 2.5, 3.5, and 4.5 hours after substance administration. | |
Other | Metabolomics concentration | Blood samples will be collected to measure metabolomics | Acute dosing day:baseline (-0.5 hour), at 1.5 and 7 hours after substance administration. | |
Other | Inflammatory cytokines | Blood samples will be collected to measure inflammatory cytokine levels | Acute dosing day:baseline (-0.5 hour), at 1.5 hours and 2 days after substance administration. | |
Other | Aftercare | Any lasting negative effects of the drug will be assessed via a visual analogue scale (VAS). | At the end of the 2 day followup | |
Primary | Neural synchrony | Quantification of neural synchrony between members of a couple utilizing previously validated naturalistic interaction paradigms, including a motor cooperation task, empathy giving task, and affective touch and eye contact paradigm, will be employed. Resting state EEG will be used as a control. | On the acute dosing test day, 1.5-2 hours after substance administration | |
Secondary | Empathy | Cognitive and emotional empathy will be assessed via the empathy giving task (EGT) and the multifaceted empathy test (MET). | On the acute dosing test day, 2 hours (EGT) and 3 hours (MET) after substance administration | |
Secondary | Self-other distinction | The degree of self-other merging will be assessed using synchronous multisensory stimulation (SMS), and responses on the inclusion of other in the self scale (OIS). | On the acute dosing day, 2.5 hours (SMS) after substance administration. The OIS will be administered repeatedly at baseline (-0.5 hours), 2 hours, 3 hours, 4.5 hours, and 7 hours after substance administration, and at 2 days follow up. | |
Secondary | Prosocial behavior | Prosocial behavior will be assessed via participants' response rate on the prosocial learning task (PLT), and the amount of effort for other individual in the prosocial effort task (PET). | On the acute dosing day, 6 hours after substance administration. The PET will also be administered at 2 days follow-up. | |
Secondary | Social influence processing | Social influence processing will be assessed via participants' degree of rating adjustment after feedback in the social influence paradigm (SIP). | On the acute dosing day, 3 hours after substance administration | |
Secondary | Trust | The trust game for couples (TGC) will assess participants' willingness to invest personal resources in pro-relationship attitudes. | On the acute dosing day, 6.5 hours after substance administration | |
Secondary | Creativity | Creativity will be assessed by the semantic distance in the chain free association (CFO) and the divergent association tasks (DAT), and also by the ability to separate old and new information in the pattern separation task (PST). | On the acute dosing day, 5.5 hours (CFO, PST) after substance administration. The DAT will be administered at 2 days follow-up. | |
Secondary | Sociality | Sociality will be measured by the social reward questionnaire (SRQ) and the visual analogue scales that measure feelings of social behavior (VAS-S). | On the acute dosing day, SRQ will be administered at 4.5 hours after substance administration, while the VAS-S will be administered at baseline (-0.5 hours), at 1, 2, 3, 4, 5, 6, and 7 hours after substance administration. | |
Secondary | Conflict resolution | The couples conflict resolution (CR) task will measure the duration of positive and negative behavior of members of a couple via video recordings of couples' interactions. | At 2 days follow-up. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06019429 -
Promoting Social-emotional Development and Self-esteem in Primary School Students
|
N/A | |
Recruiting |
NCT05639465 -
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
|
N/A | |
Completed |
NCT04889508 -
Investigating Differential Effects of Online Mental Training Interventions on Mental Well-being and Social Cohesion
|
N/A | |
Not yet recruiting |
NCT06136676 -
From the Heart: Comparing the Effects of Spiritual and Secular Meditation on Psychophysiology, Cognition, Mental Health, and Social Functioning in Healthy Adults
|
N/A | |
Completed |
NCT01459835 -
Media Impact on Preschool Behavior
|
N/A | |
Not yet recruiting |
NCT06203288 -
Well-being in Students and Teachers Study
|
N/A |